Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 2
1995 1
1998 1
1999 2
2001 4
2002 1
2003 1
2005 1
2006 2
2007 1
2008 2
2010 3
2011 1
2012 2
2013 2
2014 2
2015 3
2016 5
2018 4
2019 4
2020 1
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.
Solomon SD, Adams D, Kristen A, Grogan M, González-Duarte A, Maurer MS, Merlini G, Damy T, Slama MS, Brannagan TH 3rd, Dispenzieri A, Berk JL, Shah AM, Garg P, Vaishnaw A, Karsten V, Chen J, Gollob J, Vest J, Suhr O. Solomon SD, et al. Among authors: slama ms. Circulation. 2019 Jan 22;139(4):431-443. doi: 10.1161/CIRCULATIONAHA.118.035831. Circulation. 2019. PMID: 30586695 Clinical Trial.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Among authors: slama ms. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
Imaging inflammatory cardiomyopathies.
Le Guludec D, Sarda L, Rouzet F, Merlet P, Slama MS, Lebtahi R. Le Guludec D, et al. Among authors: slama ms. J Nucl Cardiol. 2005 Nov-Dec;12(6):731-9. doi: 10.1016/j.nuclcard.2005.09.005. J Nucl Cardiol. 2005. PMID: 16344235 Review. No abstract available.
Current and future treatment of amyloid neuropathies.
Adams D, Cauquil C, Theaudin M, Rousseau A, Algalarrondo V, Slama MS. Adams D, et al. Among authors: slama ms. Expert Rev Neurother. 2014 Dec;14(12):1437-51. doi: 10.1586/14737175.2014.983905. Epub 2014 Nov 21. Expert Rev Neurother. 2014. PMID: 25416603 Review.
Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers.
Beauvais D, Labeyrie C, Cauquil C, Francou B, Eliahou L, Not A, Echaniz-Laguna A, Adam C, Slama MS, Benmalek A, Leonardi L, Rouzet F, Adams D, Algalarrondo V, Beaudonnet G. Beauvais D, et al. Among authors: slama ms. J Neurol Neurosurg Psychiatry. 2023 Oct 24:jnnp-2023-332180. doi: 10.1136/jnnp-2023-332180. Online ahead of print. J Neurol Neurosurg Psychiatry. 2023. PMID: 37875336 Free article.
Indications of anti-inflammatory drugs in cardiac diseases.
Algalarrondo V, Boycott H, Eliahou L, Mabille M, Slama MS. Algalarrondo V, et al. Among authors: slama ms. Antiinflamm Antiallergy Agents Med Chem. 2013;12(1):3-13. doi: 10.2174/1871523011312010003. Antiinflamm Antiallergy Agents Med Chem. 2013. PMID: 23286286 Review.
47 results